Detection of Extended-spectrum ?-lactamases (ESBLS) Among Enterobacteriaceae Inside Departments of Sabha Medical Center Hospital, Especially Nursery Department and Outpatient of Sabha City , Fazzan Area in Southwestern of LIBYA

Authors

Keywords:

Enterobacteriaceae, Sabha, Nursery Department, outpatient, LIBYA.

Abstract

To estimate a rate of spread of ESBL-producing Enterobacteriaceae among out and inpatient Sabha Medical Center in stool, urine samples.  ESBLS activities were tested by the double disk synergy. The isolates were Escherichia coli 83(47.7%), 42(24.13%), Klebsiella spp. 21(12.0%), 11(6.3%), other type of Enterobacteriaceae 13(7.4%) 4(2.29%) for in and outpatient respectively. Forty four (25.28%) ESBLs strains were detected in 54.5%, 11.36% of E. coli, 15.9%, 4.5% of Klebsiella spp., 11.36%, 2.27%of other, for in and outpatient respectively. Prevalence rates 22.72%, 13.6%, 11.36 %, 9.09 % , 6.81% , 6.81 %,4.5% , 4.5% , 2.27% of ESBLs were isolated from patients on the Nursery, Medicine, surgery , Pediatric, Urology, Obstetric, Kidney Ward, ICU and ophthalmic department respectively. Fecal carriage of ESBLs is 34% 6.8% for in and outpatient. Our study has provided a first ESBLS screening for Enterobacteriaceae in Sabha Medical Center. Faecal ESBLS-producing Enterobacteriaceae for   inpatient is referring to the weakly antimicrobial policy implemented in the hospital and the aware risk of the spread it in the community. ESBLS- E. infection is prominent in Urinary Tract Infection for Nursery department and seems demonstrates the outbreak state in the hospital.

Author Biography

Aisha M. A. Shahlol, Department of Medical Laboratory Technology at Faculty of Engineering &Technology at Sabha University in LIBYA.

medical microbiology and medical lab technology

References

[1] P.A. Bradford. “Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat”. Clinical Microbiology Reviews, vol. 14, pp. 933-51, Oct. 2001.
[2] Y. Doi, Y.S. Park, J.I. Rivera, etal. “Community-associated extended-spectrum?-lactamase-producing Escherichia coli infection in the United States”. Clinical Infectious Diseases, vol. 56, pp. 641-8, Mar. 2013.
[3] M.M. D'Andrea, F. Arena, L. Pallecchi, G.M. Rossolini. “CTX-M-type ?-lactamases.a successful story of antibiotic resistance”. International Journal of Medical Microbiology, vol. 303, pp.305-17, Aug. 2013.
[4] C. Lascols, M. Hackel, A.M. Hujer, et al. “Using nucleic acid microarrays to perform molecular epidemiology and detect novel ?-lactamases. a snapshot of extended-spectrum ?-lactamases throughout the world” . Journal of Clinical Microbiology, vol. 50, pp.1632-9, May 2012.
[5] M. Gazin, F. Paasch, H. Goossens, et al. “Current trends in culture-based and molecular detection of extended-spectrum-?-lactamase-harboring and carbapenem-resistant Enterobacteriaceae” . Journal of Clinical Microbiology, vol. 50, pp. 1140-6, Apr .2012.
[6] P.L. Woerther, C. Burdet, E. Chachaty, A. Andremont. “Trends in human fecal carriage of extended-spectrum ?-lactamases in the community: toward the globalization of CTX-M”. Clinical Microbiology Review, vol. 26, pp. 744-58, Oct. 2013.
[7] A.M. Hammerum, J. Larsen, V.D. Andersen, et al. “Characterization of extended-spectrum ?-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins”. Journal of Antimicrobial Chemotherapy, vol. 69, pp. 2650-7, Oct. 2014.
[8] H .Shi, F. Sun, J. Chen, etal. “Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial - Escherichia coli infection in China”. Annals of Clinical Microbiology and Antimicrobials , vol. 14, pp.4, Jan. 2015, DOI 10.1186/s12941-015-0063-7.
[9] Clinical and Laboratory Standards Institute. (2015, Jan.) “Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement M100-S25”. Clinical and Laboratory Standards Institute, Wayne, PA. [on–line]. 35(3), http://shop.clsi.org/c.1253739/site/Sample_pdf/M100S25_sample.pdf: (Accessed on May 14, 2015).
[10] K.S. Thomson, E.S. Moland. “Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium”. Microbes and Infection, vol. 2, pp. 1225-35, Aug. 2000.
[11] A. A. Abujnah, A. Zorgani, M. A. M. Sabri, H. El-Mohammady, R. A. Khalek, K. S. Ghenghesh. “Multidrug resistance and extended-spectrum ?-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya”. Libyan Journal of Medicine, vol. 10, pp. 26412, Feb. 2015.
[12] K. S. Ghenghes , A. Rahouma, K. Tawil, A. Zorgani, E. Franka“ Antimicrobial resistance in Libya: 1970–2011” . Libyan Journal of Medicine, vol.8, pp. 20567, Mar.2013.
[13] J. Isendahl, A. Turlej-Rogacka, C. Manjuba, A. Rodrigues, C.G. Giske, P. Naucler, “ Fecal carriage of ESBL-producing E. coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based crosssectional study” . PLoS ONE, vol. 7, pp. e51981, Dec. 2012.
[14] S. Ghafourian, Z. Sekawi, V. Neela, S. Khosravi, M. Rahbar N. Sadeghifard. “Incidence of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection”. Sao Paulo Medical Journal, vol. 130, pp. 37-43, 2012.
[15] S. Haller, C. Eller, and J. Hermes etal. “What caused the outbreak of ESBL-producing Klebsiella pneumoniae in a neonatal intensive care unit, Germany2009 to 2012? Reconstructing transmission with epidemiological analysis and whole-genome sequencing”. BMJ Open. Vol. 5, pp. e007397, Aug. 2015, doi:10.1136/bmjopen-2014-007397.
[16] N. O'Connell , D. Keating, J. Kavanagh, K. Schaffer. “Detection and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in high-risk patients in an Irish tertiary care hospital”. The Journal of Hospital Infection, vol. 90, pp. 102-7, Jun. 2015. doi: 10.1016/j.jhin.
[17] A.F. Tawfik, A.M. Alswailem, Shibl, M.H. Al-Agamy. “Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia”. Microbial Drug Resistance, vol. 17, pp. 383-8, Sep. 2011.
[18] K. S. Saroj, S. Hemalatha. “Extended spectrum Beta lactamase (ESBL) Mechanism of antibiotic resistance and Epidemiology”. International Journal of PharmTech Research, International Journal of Pharm Tech Research, vol. 7, pp. 303-309, 2014-2015, ISSN: 0974-4304.
[19] N.S. Fam , S. Defasque , F. Bert. “Faecal carriage of extended-spectrum ?-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study”. Epidemiology and Infection, vol. 143, pp. 1247-55, Apr. 2015. doi: 10.1017/S0950268814001812.
[20] M. Hilty, B.Y. Betsch, K. Bögli-Stuber. “Transmission dynamics of extended-spectrum?-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting”. Clinical Infection Disease, vol. 55, pp. 967-975, June 2012.

Downloads

Published

2015-09-23

How to Cite

Shahlol, A. M. A. (2015). Detection of Extended-spectrum ?-lactamases (ESBLS) Among Enterobacteriaceae Inside Departments of Sabha Medical Center Hospital, Especially Nursery Department and Outpatient of Sabha City , Fazzan Area in Southwestern of LIBYA. American Scientific Research Journal for Engineering, Technology, and Sciences, 14(1), 204–213. Retrieved from https://asrjetsjournal.org/index.php/American_Scientific_Journal/article/view/968